FRANKFURT, April 3 The world's largest dialysis
company Fresenius Medical Care expects its ongoing
cost cutting programme to yield annual efficiency gains of $300
million from 2017, it said on Thursday.
FMC launched a cost-cutting programme last year to cope with
tougher conditions in the United States as part of which it
could shut ten or more clinics and freeze hiring.
It previously predicted savings of up to $60 million this
year and higher sums in 2015 and 2016.
FMC, which makes kidney dialysis machines and operates more
than a third of dialysis treatment centres in the United States,
in February forecast a shock fall in net profit for this year
due to healthcare spending cuts in the U.S.
In slides presented to analysts in New York and posted on
the company's website on Thursday, Chief Financial Officer Mike
Brosnan also said he expected net income to grow in the high
single digit percentage range per year from 2015 until 2020.
It earlier predicted sales to almost double to $28 billion
by 2020, driven by growing patient numbers and as it aims to
widen its services to medical fields related to kidney failure.
(Reporting by Ludwig Burger and Frank Siebelt; Editing by